Improved bioengineered cartilage tissue formation following cyclic compression is dependent on upregulation of MT1-MMP

Journal of Orthopaedic Research

Volumn 28, Issue 7, 2010, Pages 921-927

  Amrith De Croos, J N ^a   Roughley, Peter J ^b   Kandel, Rita A ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cartilage; Decoy oligodeoxynucleotide; Mechanical stimulation; siRNA

Indexed keywords

AGGRECAN; COLLAGENASE 3; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CARTILAGE; COMPRESSION; CONTROLLED STUDY; COW; GENE EXPRESSION; MECHANICAL STIMULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BIOENGINEERING; CARTILAGE, ARTICULAR; CATTLE; CHONDROCYTES; COMPRESSIVE STRENGTH; EXTRACELLULAR MATRIX; GENE EXPRESSION; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 14; METACARPUS; RNA, SMALL INTERFERING; STRESS, MECHANICAL; UP-REGULATION;

EID: 77953221110     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21064     Document Type: Article

References (46)

1. Barrack RL. 200. Early failure of modern cemented stems. J Arthroplasty 15:1036-1050.
2. Micheli L, Curtis C, Shervin N. 2006. Articular cartilage repair in the adolescent athlete: is autologous chondrocyte implantation the answer? Clin J Sport Med 16:465-470.
3. Shah MR, Kaplan KM, Meislin RJ, et al. 2007. Articular cartilage restoration of the knee. Bull NYU Hosp Jt Dis 65: 51-60.
4. Waldman SD, Grynpas MD, Pilliar RM, et al. 2002. Characterization of cartilagenous tissue formed on calcium polyphosphate substrates in vitro. J Biomed Mater Res 62:323-330.
5. Kandel RA, Grynpas M, Pilliar R, et al. 2006. Repair of osteochondral defects with biphasic cartilage-calcium polyphosphate constructs in a sheep model. Biomaterials 27: 4120-4131.
6. De Croos JN, Kandel RA. 2006. Tissue engineering of cartilage. In: Wnek A, Bowlin G, editors. Encyclopedia of biomaterials and biomedical engineering. New York: Taylor & Francis.
7. Lima EG, Mauck RL, Han SH, et al. 2004. Functional tissue engineering of chondral and osteochondral constructs. Biorheology 41:577-590. (Pubitemid 39277114)
8. Mauck RL, Nicoll SB, Seyhan SL, et al. 2003. Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng 9:597-611.
9. Waldman SD, Spiteri CG, Grynpas MD, et al. 2003. Long-term intermittent shear deformation improves the quality of cartilaginous tissue formed in vitro. J Orthop Res 21:590-596.
10. Waldman SD, Spiteri CG, Grynpas MD, et al. 2003. Effect of biomechanical conditioning on cartilaginous tissue formation in vitro. J Bone Joint Surg Am 85- (Suppl 2):101-105.
11. Waldman SD, Couto DC, Grynpas MD, et al. 2006. A single application of cyclic loading can accelerate matrix deposition and enhance the properties of tissue-engineered cartilage. Osteoarthritis Cartilage 14:323-330.
12. De Croos JN, Dhaliwal SS, Grynpas MD, et al. 2006. Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation. Matrix Biol 25:323-331.
13. De Croos JN, Jang B, Dhaliwal SS, et al. 2007. Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes. Osteoarthritis Cartilage.
14. De Croos JN, Pilliar RM, Kandel RA. 2008. AP-1 DNA binding activity regulates the cartilage tissue remodeling process following cyclic compression in vitro. Biorheology 45:459.
15. Itoh Y, Seiki M. 2006. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206:1-8.
16. d'Ortho MP, Will H, Atkinson S, et al. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751-757.
17. Ohuchi E, Imai K, Fujii Y, et al. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446-2451.
18. Boyd PJ, Doyle J, Gee E, et al. 2005. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol 288: C659-C668.
19. Haas TL, Davis SJ, Madri JA. 1998. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273:3604-3610.
20. Holmbeck K, Bianco P, Chrysovergis K, et al. 2003. MT1- MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol 163:661-671.
21. Holmbeck K, Bianco P, Caterina J, et al. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
22. Takino T, Miyamori H, Watanabe Y, et al. 2004. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 64:1044-1049.
23. Hotary KB, Allen ED, Brooks PC, et al. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114:33-45.
24. Deryugina EI, Bourdon MA, Reisfeld RA, et al. 1998. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase- 2. Cancer Res 58:3743-3750.
25. Tsunezuka Y, Kinoh H, Takino T, et al. 1996. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 56:5678-5683. (Pubitemid 26422172)
26. Boyle J, Luan B, Cruz TF, et al. 1995. Characterization of proteoglycan accumulation during formation of cartilagenous tissue in vitro. Osteoarthritis Cartilage 3:117-125.
27. Filiaggi MJ, Wells JD, Peel SAF, et al. 1998. Condensed calcium phosphates for soft tissue and bone repair/regeneration. Bioceramics 11:341-344.
28. Pilliar RM, Filiaggi MJ, Wells JD, et al. 2001. Porous calcium polyphosphate scaffolds for bone substitute applications - in vitro characterization. Biomaterials 22:963-972.
29. Sztrolovics R, Alini M, Roughley PJ, et al. 1997. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 326(Pt 1):235-241.
30. Bielinska A, Shivdasani RA, Zhang LQ, et al. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250:997-1000.
31. Peterkofsky B, Diegelmann R. 1971. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988-994.
32. Sun Y, Kandel R. 1999. Deep zone articular chondrocytes in vitro express genes that show specific changes with mineralization. J Bone Miner Res 14:1916-1925.
33. Kim YJ, Sah RL, Doong JY, et al. 1988. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174:168-176.
34. Goldberg RL, Kolibas LM. 1990. An improved method for determining proteoglycans synthesized by chondrocytes in culture. Connect Tissue Res 24:265-275.
35. Woessner JF. 1976. Determination of hydroxyproline content in connective tissues. In: Hall DA, editor. The methodology of connective tissue research. Oxford: Joynson-Bruvvers Limited.
36. Holschermann H, Stadlbauer TH, Wagner AH, et al. 2006. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival. Cardiovasc Res 71:527-536.
37. Morishita R, Aoki M, Kaneda Y. 2001. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease. Ann N Y Acad Sci 947:294-301.
38. Yamaguchi S, Yamaguchi M, Yatsuyanagi E, et al. 2002. Cyclic strain stimulates early growth response gene product 1- mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest 82:949-956. (Pubitemid 34761670)
39. Yun S, Dardik A, Haga M, et al. 2002. Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium. J Biol Chem 277:34808-34814.
40. Kim D, Rossi J. 2008. RNAi mechanisms and applications. BioTechniques 44:613-616.
41. Tan L, Peng H, Osaki M, et al. 2003. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 278:17688-17700.
42. Chakraborti S, Mandal M, Das S, et al. 2003. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269-285.
43. Liacini A, Sylvester J, Li WQ, et al. 2003. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288:208-217.
44. Chun TH, Sabeh F, Ota I, et al. 2004. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167:757-767.
45. Bartolome RA, Molina-Ortiz I, Samaniego R, et al. 2006. Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res 66:248-258.
46. Spiteri CG, Young EW, Simmons CA, et al. 2008. Substrate architecture and fluid-induced shear stress during chondrocyte seeding: role of alpha5beta1 integrin. Biomaterials 29: 2477-2489.